Most Sinus Membrane Perforations Occur During Implant Placement in Crestal Sinus Elevation Procedures

A new study published in the Journal of Oral Implantology reports that sinus membrane perforations most frequently occur during implant placement in crestal sinus elevation procedures. Researchers ...
Nature

Maxillary Sinus Floor Elevation And Augmentation

Maxillary sinus floor elevation and augmentation is a surgical procedure developed to increase bone volume in the atrophic posterior maxilla, thereby facilitating the precise placement of dental ...
Healthline

Everything to Know About a Sinus Lift

Sinus lift surgery is a treatment approach your dentist may recommend when you desire dental implants but don’t have enough jaw bone to secure the implant. Other names for this procedure include sinus ...
DrBicuspid

Short vs. long implants: How do the results measure up?

How do the long-term results of short implants compare with those of long implants placed after maxillary sinus augmentation? To get a clear look at the risks and benefits of each, researchers ...
Business Wire

EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Business Wire

Intersect ENT Announces Publication of Pooled Analysis of Steroid Releasing Implants in Patients Following Frontal Sinus Surgery

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a ...
News Medical

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Intersect ENT, Inc., a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a pooled analysis in the International Forum of Allergy ...
Nasdaq

Intersect ENT Announces CMS Approval of Coding Application for PROPEL® Sinus Implant

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Nasdaq

Intersect ENT Announces Independent Analysis in UK Confirming Cost Effectiveness of PROPEL® Steroid Releasing Sinus Implant Following Sinus Surgery for Chronic Sinusitis

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the results of a ...